Skip to main content
. 2020 Nov 16;12(5):704–712. doi: 10.1021/acsmedchemlett.0c00588

Table 4. Antimycobacterial Profiles of Indolecarboxamide 16 and Indolylmethylamine 33.

        M. bovis BCG (μM)
 
  M. tb H37Rv (μM)
  MIC50/MIC90 in 7H9 media
 
no. MIC50a MIC90a MBC99.9b MBC99.9b standard media no glycerol with 10% FBS Vero IC50 (μM)c
16 0.02 0.04 0.08 0.08 0.02/0.04 0.01/d 0.02/0.08 >100
33 0.05 0.13 0.63 0.16 0.04/0.08 0.04/d 0.07/0.16 22 ± 2
a

Lowest concentration required to reduce bacterial growth by 50% (MIC50) or 90% (MIC90) compared to untreated cultures. MIC50 and MIC90 of isoniazid (control) on M. tb were 1.8 μM and 3.8 μM.

b

Minimum compound concentration required to kill 99.9% of bacteria. Control isoniazid had MBC99Mtb of 3.2 μM and MBC99.9BCG of 10 μM.

c

Concentration required to reduce growth of mammalian Vero cells by 50% compared to untreated controls. Selectivity indices (IC50Vero/MIC50, SIs) for 16 was >5000 (M. tb, M. bovis BCG), and for 33, SI was 366 (M. tb) and 550 (M. bovis BCG).

d

MIC90 could not be accurately determined in 7H9 in the absence of glycerol due to poor bacterial growth.